Judy Chiao
Keine laufenden Positionen mehr
Profil
Judy Chiao worked as VP-Oncology Clinical Research & Development at Aton Pharma, Inc. from 2002 to 2004.
She then worked as VP-Clinical Development & Regulatory Affairs at Cyclacel Pharmaceuticals, Inc. from 2004 to 2021.
Chiao received her undergraduate degree from The Trustees of Columbia University in The City of New York and her doctorate degree from Harvard Medical School.
Ehemalige bekannte Positionen von Judy Chiao
| Unternehmen | Position | Ende |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.03.2021 |
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Corporate Officer/Principal | 01.12.2004 |
Ausbildung von Judy Chiao
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Health Technology |
